B2M and pulmonary fibrosis: In this retrospective study, we tested the hypothesis that increased β2M serum and lung levels lead to diffusion dysfunction and pulmonary fibrosis development (DLCO decreasing, alveolar-related EMT, lung tissue fibrosis) in COPD patients.